258 related articles for article (PubMed ID: 27563015)
1. Helicobacter pylori Eradication Therapy, the Reasonable First Line Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Irrespective of Infection Status and Disease Stages.
Cheung DY
Gut Liver; 2016 Sep; 10(5):659-60. PubMed ID: 27563015
[No Abstract] [Full Text] [Related]
2. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
Gong EJ; Ahn JY; Jung HY; Park H; Ko YB; Na HK; Jung KW; Kim do H; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
Gut Liver; 2016 Sep; 10(5):706-13. PubMed ID: 27114423
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
Choi YJ; Kim N; Paik JH; Kim JM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC
Helicobacter; 2013 Jun; 18(3):197-205. PubMed ID: 23305046
[TBL] [Abstract][Full Text] [Related]
4. Treatment of gastric marginal zone lymphoma of MALT type.
Stathis A; Bertoni F; Zucca E
Expert Opin Pharmacother; 2010 Sep; 11(13):2141-52. PubMed ID: 20586708
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of endoscopic appearance for choosing a biopsy target site and determining complete remission of primary gastric lymphoma of mucosa-associated lymphoid tissue after eradication of Helicobacter pylori infection.
Ishihara R; Tatsuta M; Iishi H; Uedo N; Narahara H; Ishiguro S
Am J Gastroenterol; 2002 Mar; 97(3):772-4. PubMed ID: 11922590
[No Abstract] [Full Text] [Related]
6. Eradication therapy in Helicobacter pylori-negative, gastric low-grade mucosa-associated lymphoid tissue lymphoma patients: a systematic review.
Zullo A; Hassan C; Ridola L; De Francesco V; Rossi L; Tomao S; Vaira D; Genta RM
J Clin Gastroenterol; 2013; 47(10):824-7. PubMed ID: 23442842
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter and gastric MALT lymphoma.
Stolte M; Bayerdörffer E; Morgner A; Alpen B; Wündisch T; Thiede C; Neubauer A
Gut; 2002 May; 50 Suppl 3(Suppl 3):III19-24. PubMed ID: 11953328
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori eradication therapy in primary high-grade gastric MALT lymphoma.
Fischbach W
Gastroenterology; 2002 Jul; 123(1):393. PubMed ID: 12105882
[No Abstract] [Full Text] [Related]
9. Thoughts on the eradication of Helicobacter pylori infection in localized gastric mucosa-associated lymphoid tissue lymphoma.
Zinzani PL
Leuk Lymphoma; 2006 Oct; 47(10):2013-4. PubMed ID: 17071470
[No Abstract] [Full Text] [Related]
10. Eradication of Helicobacter pylori and stability of remissions in low-grade gastric B-cell lymphomas of the mucosa-associated lymphoid tissue: results of an ongoing multicenter trial.
Thiede C; Wündisch T; Neubauer B; Alpen B; Morgner A; Ritter M; Ehninger G; Stolte M; Bayerdörffer E; Neubauer A
Recent Results Cancer Res; 2000; 156():125-33. PubMed ID: 10802872
[TBL] [Abstract][Full Text] [Related]
11. Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection.
Morgner A; Miehlke S; Fischbach W; Schmitt W; Müller-Hermelink H; Greiner A; Thiede C; Schetelig J; Neubauer A; Stolte M; Ehninger G; Bayerdörffer E
J Clin Oncol; 2001 Apr; 19(7):2041-8. PubMed ID: 11283137
[TBL] [Abstract][Full Text] [Related]
12. Our experience in Helicobacter pylori infection and gastric MALToma.
Losacco T; Cagiano R; Bottalico L; Carlaio RG; Prejbeanu R; Vermesan H; Dragulescu SI; Vermesan D; Motoc A; Santacroce L
Clin Ter; 2008; 159(4):239-42. PubMed ID: 18776980
[TBL] [Abstract][Full Text] [Related]
13. Gastric mucosal-associated lymphoid tissue lymphoma.
Fischbach W
Gastroenterol Clin North Am; 2013 Jun; 42(2):371-80. PubMed ID: 23639646
[TBL] [Abstract][Full Text] [Related]
14. Changes in pattern of immunoglobulin heavy chain gene rearrangement and MIB-1 staining before and after eradication of Helicobacter pylori in gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
Kanda M; Suzumiya J; Ohshima K; Okada M; Tamura K; Kikuchi M
Leuk Lymphoma; 2001 Aug; 42(4):639-47. PubMed ID: 11697492
[TBL] [Abstract][Full Text] [Related]
15. Second cancers and residual disease in patients treated for gastric mucosa-associated lymphoid tissue lymphoma by Helicobacter pylori eradication and followed for 10 years.
Wündisch T; Dieckhoff P; Greene B; Thiede C; Wilhelm C; Stolte M; Neubauer A
Gastroenterology; 2012 Oct; 143(4):936-42; quiz e13-4. PubMed ID: 22750463
[TBL] [Abstract][Full Text] [Related]
16. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
Levy M; Copie-Bergman C; Traulle C; Lavergne-Slove A; Brousse N; Flejou JF; de Mascarel A; Hemery F; Gaulard P; Delchier JC;
Am J Gastroenterol; 2002 Feb; 97(2):292-7. PubMed ID: 11866264
[TBL] [Abstract][Full Text] [Related]
17. Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy.
Caletti G; Togliani T; Fusaroli P; Sabattini E; Khodadadian E; Gamberi B; Gobbi M; Pileri S
Gastroenterology; 2003 Feb; 124(2):537-43. PubMed ID: 12557157
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease.
Kim JS; Chung SJ; Choi YS; Cheon JH; Kim CW; Kim SG; Jung HC; Song IS
Br J Cancer; 2007 May; 96(9):1324-8. PubMed ID: 17406363
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR
Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137
[TBL] [Abstract][Full Text] [Related]
20. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
Falcó Jover G; Martínez Egea A; Sánchez Cuenca J; Onrubia Pintado J; García Lafuente N; Ruiz Gómez F; Coronas Planas M
Rev Esp Enferm Dig; 1999 Aug; 91(8):541-8. PubMed ID: 10491486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]